Increased T Cell Recruitment to the CNS after Amyloid β(1–42) Immunization in Alzheimer's Mice Overproducing Transforming Growth Factor-β1

Immunotherapy targeting the amyloid β (Aβ) peptide is a novel therapy under investigation for the treatment of Alzheimer's disease (AD). A clinical trial using Aβ(1–42) (AN1792) as the immunogen was halted as a result of development of meningoencephalitis in a small number of patients. The cyto...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Buckwalter, Marion S., Coleman, Bronwen S., Buttini, Manuel, Barbour, Robin, Schenk, Dale, Games, Dora, Seubert, Peter, Wyss-Coray, Tony
Formato: Artigo
Idioma:Inglês
Publicado em: Society for Neuroscience 2006
Assuntos:
Brief Communications
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1892201/
https://ncbi.nlm.nih.gov/pubmed/17079673
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1523/JNEUROSCI.2436-06.2006
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados